MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BORCHARDT, R. T.
Right arrow Articles by ADAMS, R. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BORCHARDT, R. T.
Right arrow Articles by ADAMS, R. N.

Molecular Pharmacology, Vol 13, 805-818, Copyright © 1977 by the American Society for Pharmacology and Experimental Therapeutics

Effects of 2-and/or 5-Methylated Analogues of 6-Hydroxydopamine on Norepinephrine- and Dopamine-Containing Neurons

RONALD T. BORCHARDT 1, SUSAN K. BURGESS 1, JACK R. REID 1, YUEH-O LIANG 2, and RALPH N. ADAMS 2

1 Department of Biochemistry, McCollum Laboratories, University of Kansas, Lawrence, Kansas 66044
2 Department of Chemistry, University of Kansas, Lawrence, Kansas 66045

To characterize further the molecular mechanism whereby 6-hydroxydopamine (6-OHDA) exerts its cytotoxic effects, a series of 2-and/or 5-methylated derivatives of 6-OHDA was prepared. These analogs exhibit oxidation-reduction potentials similar to that of 6-OHDA, but the corresponding quinones showed different reactivities toward nucleophiles in vitro. The quinone forms of 6-OHDA and 5-methyl-6-OHDA reacted with glutathione, whereas 2-methyl-6-OHDA quinone reacted very slowly, if at all, and 2,5-dimethyl-6-OHDA quinone was unreactive. In vivo both 6-OHDA and 5-methyl-6-OHDA were shown to produce long-term depletion of norepinephrine in mouse brain, whereas 2-methyl-6-OHDA and 2,5-dimethyl-6-OHDA were substantially less active. Only 6-OHDA produced long-term depletion of dopamine. These compounds were also tested for their abilities to inhibit uptake or cause release of [3H]norepinephrine or [3H]dopamine, using chopped rat cerebral cortex or corpus striatum. The observed order of potencies for both release and inhibition of uptake was 6-OHDA > 2-methyl-6-OHDA cong 5-methyl-6-OHDA > 2,5-dimethyl-6-OHDA. The differences in potency between 6-OHDA and 5-methyl-6-OHDA in producing long-term depletion of catecholamines can be explained on the basis of differences in affinities for the uptake systems. However, the differences in potency between 5-methyl-6-OHDA and 2-methyl-6-OHDA in producing long-term norepinephrine depletion cannot be rationalized on a similar basis. A more reasonable explanation for this difference is that 5-methyl-6-OHDA quinone can react with cellular nucleophiles, whereas 2-methyl-6-OHDA quinone cannot. Therefore 5-methyl-6-OHDA produces neuronal destruction through a mechanism similar to that of 6-OHDA, that being generation of a reactive electrophilic species, as well as hydrogen peroxide, superoxide anion, and hydroxyl radical. In contrast, the neurotoxicity produced by 2-methyl-6-OHDA probably results only from the effects of hydrogen peroxide, superoxide anion, and hydroxyl radical.

Submitted on January 5, 1977
Accepted on April 6, 1977







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1977 by the American Society for Pharmacology and Experimental Therapeutics